Internal Medicine, Cardiovascular Disease · Bakersfield, CA
NPI
1609055078
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2901 Sillect Ave, Suite 100
Bakersfield, CA, 93308
Phone (661) 323-8384
Groups this clinician bills Medicare through
Medicare paid, 2024
$422K
10,620 services
Medicare patients, 2024
1,250
Average age 76
Drug cost, 2024
$669K
6,161 prescriptions
Company payments, 2025
$1,341
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter Nalos was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,501 times for 15 patients. In total Peter Nalos billed 10,620 services in 90 codes, and Medicare paid $422K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-10-29.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,501 | 15 | $0.10 | $156 |
| 93296 External Electrocardiographic Monitoring | Office | 1,316 | 419 | $16.79 | $22K |
| 93294 External Electrocardiographic Monitoring | Office | 1,001 | 317 | $21.20 | $21K |
| 93297 External Electrocardiographic Monitoring | Office | 835 | 118 | $47.92 | $40K |
| 93280 External Electrocardiographic Monitoring | Office | 831 | 371 | $57.56 | $48K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 825 | 475 | $12.12 | $9,996 |
| 99213 Office E&M - Established | Office | 684 | 442 | $64.73 | $44K |
| 99212 Office E&M - Established | Office | 430 | 309 | $36.37 | $16K |
| 93298 External Electrocardiographic Monitoring | Office | 404 | 51 | $81.47 | $33K |
| 93290 External Electrocardiographic Monitoring | Office | 370 | 132 | $39.94 | $15K |
| 93295 External Electrocardiographic Monitoring | Office | 342 | 107 | $26.83 | $9,174 |
| 99214 Office E&M - Established | Office | 291 | 219 | $101.39 | $30K |
| 93283 External Electrocardiographic Monitoring | Office | 183 | 66 | $68.84 | $13K |
| 93000 Electrocardiogram | Office | 151 | 116 | $10.45 | $1,578 |
| 93284 External Electrocardiographic Monitoring | Office | 132 | 51 | $77.98 | $10K |
By year: 2022 $551K for 10,920 services; 2023 $532K for 10,585 services; 2024 $422K for 10,620 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 12 | $8.65 | $112 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter Nalos prescribed most often to Medicare patients was Metoprolol Succinate, with 454 prescriptions and refills. In total Peter Nalos wrote 6,161 Medicare prescriptions that cost $669K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 454 | 1,039 | 128 | $7,345 |
| Flecainide Acetate Generic | 420 | 987 | 121 | $17K |
| Losartan Potassium Generic | 393 | 1,009 | 117 | $4,717 |
| Sotalol Sotalol Hcl | 392 | 1,035 | 136 | $6,945 |
| Eliquis Apixaban | 356 | 685 | 88 | $388K |
| Atorvastatin Calcium Generic | 342 | 894 | 99 | $3,040 |
| Amlodipine Besylate Generic | 337 | 857 | 110 | $2,754 |
| Amiodarone Hcl Generic | 271 | 643 | 97 | $5,246 |
| Furosemide Generic | 252 | 595 | 87 | $1,664 |
| Rosuvastatin Calcium Generic | 226 | 575 | 70 | $4,039 |
| Metoprolol Tartrate Generic | 206 | 469 | 59 | $1,269 |
| Clopidogrel Clopidogrel Bisulfate | 135 | 378 | 44 | $1,710 |
| Nebivolol Hcl Generic | 134 | 257 | 33 | $5,267 |
| Carvedilol Generic | 124 | 311 | 40 | $1,073 |
| Potassium Chloride Generic | 120 | 290 | 45 | $2,921 |
Brand drugs: 751 claims; generic drugs: 5,410 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter Nalos $1,341 ($1,341 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbott Laboratories with $989.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 25 | $989 |
| Heartflow, Inc. HTFL | 2 | $160 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $38.35 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $32.23 |
| Medtronic, Inc. MDT | 1 | $29.23 |
| Pfizer Inc. PFE | 1 | $27.8 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $22.86 |
| Scpharmaceuticals Inc. SCPH | 1 | $21.19 |
| Merck Sharp & Dohme LLC MRK | 1 | $20.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.